Rachel Md Seaman

Rachel Md Seaman

Auto-generated profile, based on publicly available information

Rachel Md Seaman

By Cesar Moreno, MD, Rachel Seaman, MD, FACP, and Kristen Noles, DNP, RN, CNL, The University of South Alabama Health System, Mobile ([ protected])

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Surgical Education
Verified
Journal Article
Closed access
DBDaniel Berman
Daniel Berman
ZBZachary Braig
Zachary Braig
BSBrian Simms
Brian Simms
TATaylor Anderson
Taylor Anderson
KDKristen Dougherty
Kristen Dougherty
RSRachel Seaman
Rachel Seaman

10 July 2020 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
PDF file
JEJimmy Espinoza
Jimmy Espinoza
BFBetul Yilmaz Furtun
Betul Yilmaz Furtun
JKJoshua A. Kailin
Joshua A. Kailin
CACarolyn A. Altman
Carolyn A. Altman
RSRachel D. Seaman
Rachel D. Seaman
WLWesley Lee
Wesley Lee

14 October 2022 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Closed access
RSRachel D. Seaman
Rachel D. Seaman
BSBahram Salmanian
Bahram Salmanian
ASAlireza A. Shamshirsaz
Alireza A. Shamshirsaz
JEJimmy Espinoza
Jimmy Espinoza
MSMagdalena Sanz-Cortes
Magdalena Sanz-Cortes
ANAhmed Nassr
Ahmed Nassr


2 March 2022 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
AAArchana Ayyar
Archana Ayyar
RSRachel D. Seaman
Rachel D. Seaman
KGKalpalatha Guntupalli
Kalpalatha Guntupalli
MTMary C. Tolcher
Mary C. Tolcher
Background. COPA syndrome is a rare autoimmune disease, demonstrating an autosomal dominant inheritance pattern with variable penetration that occurs more frequently in females than males. This disease manifests in childhood as pulmonary hemorrhage, arthritis, and renal disease. Case. We present a case of obstetric management of a 20-year-old nulligravida patient with a diagnosis of COPA syndrome. Her case was further complicated by multiple antepartum admissions for hypoxemia and a complex psychosocial history of substance use. On her first antepartum admission, rheumatology recommended management with hydroxychloroquine, inhaled corticosteroids (budesonide), and bronchodilators (albuterol inhaler) as needed. On admission for induction of labor, she was again noted to have oxygen desaturations. A chronic thrombus was noted on computed tomography (CT), and a multidisciplinary team was recommended against Valsalva. Thus, she had a primary cesarean delivery. Her postpartum course was only remarkable for improved oxygenation status. Conclusion. Management of COPA syndrome should be performed by a multidisciplinary team including maternal-fetal medicine, rheumatology, and pulmonology specialists. Traditionally, COPA syndrome is treated with immunomodulator therapy often used to treat autoimmune syndromes. However, many of these medications are not well studied or contraindicated in pregnancy. Preconception counseling is recommended both to ensure pregnancy safe medications being prescribed and to provide information on the genetic inheritance of this disease. At time of entry to care, patients should have a baseline work-up including a radiographic imaging, complete blood count, complete metabolic panel, lactate dehydrogenase, and a 24-hour urine protein collection for baseline. Although thought to be rare, COPA syndrome has an autosomal dominance pattern of inheritance with variable penetrance that is more common in females. Thus, incidence of COPA syndrome in pregnancy will likely increase in the future. Further case studies are warranted to optimize management of patients with COPA syndrome in pregnancy.

1 January 2023 in Journal of Nursing Care Quality
Verified
Journal Article
Closed access
CMCesar Moreno
Cesar Moreno
RSRachel Md Seaman
Rachel Md Seaman
KNKristen Dnp Noles
Kristen Dnp Noles